Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP510589.RAe1Y_XZHDYeZbm-iv-rQFQnQkf4YhUdyKKf1NxM73oW0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP510589.RAe1Y_XZHDYeZbm-iv-rQFQnQkf4YhUdyKKf1NxM73oW0130_assertion type Assertion NP510589.RAe1Y_XZHDYeZbm-iv-rQFQnQkf4YhUdyKKf1NxM73oW0130_head.
- NP510589.RAe1Y_XZHDYeZbm-iv-rQFQnQkf4YhUdyKKf1NxM73oW0130_assertion description "[The specific binding of insulin to either intact or Triton-solubilized Daudi cells (a Burkitt lymphoma cell line) was reduced by over 95% compared to that to control IM-9 lymphocytes due to a decrease in receptor number without a change in affinity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP510589.RAe1Y_XZHDYeZbm-iv-rQFQnQkf4YhUdyKKf1NxM73oW0130_provenance.
- NP510589.RAe1Y_XZHDYeZbm-iv-rQFQnQkf4YhUdyKKf1NxM73oW0130_assertion evidence source_evidence_literature NP510589.RAe1Y_XZHDYeZbm-iv-rQFQnQkf4YhUdyKKf1NxM73oW0130_provenance.
- NP510589.RAe1Y_XZHDYeZbm-iv-rQFQnQkf4YhUdyKKf1NxM73oW0130_assertion SIO_000772 2664477 NP510589.RAe1Y_XZHDYeZbm-iv-rQFQnQkf4YhUdyKKf1NxM73oW0130_provenance.
- NP510589.RAe1Y_XZHDYeZbm-iv-rQFQnQkf4YhUdyKKf1NxM73oW0130_assertion wasDerivedFrom befree-20150227 NP510589.RAe1Y_XZHDYeZbm-iv-rQFQnQkf4YhUdyKKf1NxM73oW0130_provenance.
- NP510589.RAe1Y_XZHDYeZbm-iv-rQFQnQkf4YhUdyKKf1NxM73oW0130_assertion wasGeneratedBy ECO_0000203 NP510589.RAe1Y_XZHDYeZbm-iv-rQFQnQkf4YhUdyKKf1NxM73oW0130_provenance.